a Background Several studies have assessed the relationship between the angiotensin-converting enzyme (ACE) I/D or angiotensin II type 1 receptor (AT 1 R)-A 1166 C polymorphisms and blood pressure (BP). Since most data have been obtained in selected populations, the present study was performed in a healthy normotensive primary care population.
C polymorphisms on blood pressure in a healthy normotensive primary care population: first results of the Hippocates study 
Introduction
Hypertension is a multifactorial complex trait [1] . Twin and family studies suggest that approximately 30% of blood pressure (BP) variations arise from genes [2] . Since multiple transplantation studies in animals and in humans have shown that the inherited tendency to hypertension predominantly resides in the kidney [3, 4] , and because the renin-angiotensin system (RAS) plays a central role in the regulation of kidney function and BP, the search for genes associated with hypertension has predominantly focused on the RAS. Two well-studied genetic polymorphisms of the RAS are the angiotensin-converting enzyme insertion/deletion (ACE I/D) polymorphism and the angiotensin II type 1 receptor (AT 1 R) A 1166 C polymorphism. The D allele of the ACE I/D polymorphism correlates with a higher plasma ACE activity and behaves as a marker of atherosclerotic cardiovascular complications, in particular myocardial infarction [5] [6] [7] [8] [9] . Its association with hypertension, however, is not beyond dispute [10, 11] . On the other hand, the presence of the C allele of the AT 1 R-A 1166 C polymorphism is associated with aortic stiffness [12, 13] and essential hypertension [14, 15] . Recently, our group [16] has shown that patients with the CC genotype exhibit increased sensitivity to angiotensin II, a finding that has been corroborated by other observations [17] .
A synergistic relationship between the presence of the D allele of the ACE I/D polymorphism and one or two C alleles of the AT 1 R-A 1166 C polymorphism has been observed in terms of BP variation and myocardial infarction [18] [19] [20] , but again, results are conflicting [21] [22] [23] [24] [25] [26] . However, most data with regard to the potential hypertensive effect of genetic polymorphisms, alone or in combination, have been obtained in selected populations, which are potentially confounded by referral bias. Furthermore, in most studies dealing with the effect of genetic polymorphisms on BP, results may have been influenced by pre-existing cardiovascular morbidity and antihypertensive treatment. Therefore, the present study aimed to assess the effect of the two aforementioned polymorphisms and their interaction on BP in healthy normotensive subjects who were drawn from a primary care practice.
Subjects and methods

Subjects
Enrolment of subjects for this cross-sectional study started in October 1997 and lasted until January 2001. All participants were recruited from a general practice in Kerkrade, The Netherlands. This academic group practice takes part in the Registration Network Family Practices [27] which provides an inter-regional longterm and thorough recording of morbidity based on the International Classification of Primary Care (ICPC). The practice has a list of 4200 subjects, among whom are more than 300 patients with hypertension. All subjects included were healthy normotensive controls of an ongoing study on cardiovascular risk (Hippocrates study). Before entering the study, subjects were matched for age and sex with a chronically treated hypertensive cohort, and inclusion was validated by thorough analysis of the subjects' records combined with additional measurements of BP and risk indicators. Reasons for exclusion were the presence of hypertension, diabetes mellitus, myocardial infarction, angina pectoris, cerebrovascular disease, intermittent claudication and use of cardiovascular medication. BP was measured after 10 min rest in a sitting position, using a sphygmomanometer. All measurements were performed in the office by one of the authors (L.H.). Hypertension was defined as systolic BP (SBP) > 160 mmHg and/or diastolic BP (DBP) > 95 mmHg according to the Guidelines on Hypertension for Dutch General Practitioners [28] . Blood samples were drawn for serum creatinine, uric acid, total cholesterol and glucose levels. Creatinine clearance was computed using Cockcroft's formula [29] .
Participants gave informed consent and the study was approved by the Medical Ethics Committee of the University Hospital Maastricht.
Genetic analysis
The ACE I/D and the AT 1 R-A 1166 C polymorphisms of the RAS were determined at the Cardiovascular Genotyping (CAGT) laboratory of the Department of Internal Medicine of the University Hospital Maastricht. DNA was extracted from whole blood with the use of the QIAamp 1 Blood Kit (Qiagen Inc., Valencia, California, USA). The ACE I/D polymorphism was detected using the technique described by Rigat et al. [30] . To determine the genotype of the AT 1 R-A 1166 C polymorphism, we adopted the mutagenically separated polymerase chain reaction (MS-PCR) technique [31] . Briefly, two allele-specific primers and their non-selective complementary strand primer were mixed and used for PCR amplification in a single reaction. In addition to the base substitution, deliberate differences were introduced into the allele-specific primers. In that way we were able to drastically reduce cross-reactions between two allelic PCRs in a mixed reaction [16] . The following primers were used (deliberate differences and base substitutions are underlined):
• FP 1166A, 59-CTC TGC AGC ACT TCA CTA CCA AAT GAT CA-39
The size of the PCR products were 190 and 210 bp for the 1166 A and 1166 C alleles, respectively. These products were resolved on a 3% agarose gel.
Statistical analysis
Differences between genotype groups were tested with analysis of variance (one-way analysis of variance, ANOVA), using Bonferroni's method for post-hoc multiple comparisons between genotype classes. Genotype frequencies between groups were compared using a ÷ 2 -test and tests for Hardy-Weinberg equilibrium were carried out using standard methods [32] . With linear regression analysis determinants of BP were investigated. Effects of the genotypes, represented by dummy-variables, were assessed using the deviation from mean coding approach [33] . The interaction between both polymorphisms on BP was tested using the following model: SBP (or DBP) ¼ b 0 + b 1 X + b 2 Y + b 3 XY, in which b represents a constant variable, X the risk allele of polymorphism X, Y the risk allele of polymorphism Y, and XY the interaction between the two. A post-hoc analysis, in which subjects were divided in a true normotensive group (SBP , 130 mmHg and DBP , 85 mmHg) and a borderline hypertensive group (SBP > 130 mmHg and DBP > 85 mmHg), was carried out to assess whether associations were similar or not in both groups.
Unless indicated otherwise, data are expressed as means AE standard error of the mean (SEM). A P value , 0.05 was considered statistically significant. Statistical analyses were performed using SPSS 10.0 for Windows (SPSS Inc, Chicago, Illinois, USA).
Results
General characteristics
Altogether, 198 subjects were included in the study. Characteristics of the study population genotyped for the ACE I/D and the AT 1 R-A 1166 C polymorphisms are summarized in Table 1 and Table 2 , respectively. In one patient, determination of the genotype of the ACE I/D polymorphism failed. With respect to the ACE I/D polymorphism no significant differences between the three different genotypes were found, with the exception of uric acid concentration, which was higher in DD subjects compared with ID subjects (P , 0.05; Table  1 ). With respect to the AT 1 R-A 1166 C polymorphism, cholesterol levels were higher in AA subjects compared to AC subjects (P , 0.05), but otherwise no significant differences between genotypes were found ( Table 2) . Genotype frequencies of both polymorphisms were in Hardy-Weinberg equilibrium.
Blood pressure and separate polymorphisms
For the ACE I/D polymorphism SBP and DBP were significantly different between genotype groups, P ¼ 0.002 and P ¼ 0.004, respectively (Fig. 1) . Post-hoc comparison of the ACE genotype classes showed a significantly higher DBP in DD homozygotes compared to both ID heterozygotes (P ¼ 0.006) and II homozygotes (P ¼ 0.015). In simple linear regression analysis body mass index (BMI) and age proved to be independent predictors of BP. Multiple linear regression analysis confirmed the association of the ACE D allele with SBP (R 2 ¼ 0.048; P ¼ 0.005) when adjusted for BMI and age, and for DBP (R 2 ¼ 0.058; P ¼ 0.001) when adjusted for BMI. This was true also for both SBP (â ¼ 0.291; P , 0.001) and DBP (â ¼ 0.238; P ¼ 0.001)
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No association between the ACE D allele and BMI or age was found. In the post-hoc analysis these associations were found in both the normotensive group and in the group of subjects with borderline hypertension.
The AT 1 R-A 1166 C polymorphism showed a significantly higher SBP in subjects with the CC genotype (P ¼ 0.025). However, after adjustment for BMI and age no association was found between the AT 1 R C allele and SBP. This was true also when the normotensive and borderline hypertensive group were considered respectively. Table 3 shows the interaction of the ACE I/D and the AT 1 R-A 1166 C alleles on BP in this population. No interaction of the ACE D and the AT 1 R C alleles on SBP (P ¼ 0.475) or DBP (P ¼ 0.688) was found in the linear regression model for interaction as described above. Since this finding does not exclude an additive effect of both alleles and because there is uncertainty with respect to the pattern of inheritance (recessive, codominant or dominant), we decided to re-analyse these data using homozygous allele combinations only, i.e. IIAA, IICC, DDAA and DDCC. With this approach, we found that the highest DBP tracked with the homozygous DDCC allele combination (Fig. 2) when compared with the other homozygous allele combinations (P ¼ 0.030).
Interaction of both polymorphisms
Discussion
In the present study, we investigated the individual and interactive influences of two polymorphisms of the RAS in normotensive healthy subjects drawn from a primary care setting. Our data show an association of Copyright © Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited. { P ¼ 0.025 (one-way ANOVA); post hoc test for multiple comparisons (Bonferroni): P ¼ 0.020 (AC versus CC). SBP, systolic blood pressure; DBP, diastolic blood pressure. Several studies investigated the association between the ACE I/D polymorphism and BP, yielding conflicting results [6, 8, [34] [35] [36] [37] [38] [39] . However, most negative studies assessed the association by taking hypertension as a qualitative trait, rather than using BP as a continuous, quantitative trait [8, 37, 39] . Furthermore, results could have been influenced by pre-existing cardiovascular morbidity and medication influencing BP (since the majority of studies was conducted in hypertensive populations) and, potentially, by referral bias. The association between ACE genotype and BP in the present study is in agreement with the findings by Uemura et al. [35] and data from the Framingham Heart Study [34] . Recently, a Japanese study [36] reported identical results, suggesting that the action of the polymorphism may be homogeneous throughout ethnic groups. Since it has been shown that the D allele is associated with higher levels of ACE [40] , an association of the ACE I/D polymorphism with BP could be explained by an increase in local angiotensin II levels. So far, however, no study has provided evidence to support this notion.
Although in the present study the highest SBP tracked with CC homozygosity for the AT 1 R-A 1166 C polymorphism, the C allele was not significantly associated with SBP in linear regression analysis. Nevertheless, Hingorani et al. [41] observed a significantly higher SBP and DBP in the presence of two AT 1 R C alleles. Others also found an association of the AT 1 R-A 1166 C polymorphism with essential hypertension and aortic stiffness, particularly in the face of increased SBP [12] [13] [14] [15] . Moreover, our group [16] recently found that the CC genotype is associated with increased sensitivity to angiotensin II. This may contribute to the increased incidence of cardiovascular abnormalities found in subjects with one or two C alleles.
Several studies have shown an interaction between ACE D and AT 1 R C alleles with respect to the risk of myocardial infarction [18] [19] [20] 42] . Since BP also may be related to multiple genes, we investigated whether there is a synergistic effect of the ACE D and AT 1 R C alleles on BP. An interaction in the sense of synergy, however, was not present in our population. Nevertheless, an additive effect was found. Analysing only homozygous allele combinations, we found an effect of both genes on DBP with the highest pressure in subjects with the DDCC allele combination. The effect was most pronounced when adding an ACE D allele (IIAA versus DDAA and IICC versus DDCC), but, also the addition of an AT 1 R C allele (IIAA versus IICC and DDAA versus DDCC) seemed to increase DBP. This is more or less in line with a recently published prospective study [43] that found an 'epistatic' interaction of the ACE I/D polymorphism with both the aldosterone synthase and AE-adducin polymorphisms on the development of hypertension. Particularly in the case of homozygosity of the ACE D allele, the risk of developing hypertension during 12 years of follow-up increased significantly.
In conclusion, this study confirmed an association of the ACE I/D polymorphism on blood pressure in a healthy normotensive primary care population. A synergistic effect between the ACE I/D and the AT 1 R-A 1166 C polymorphisms on BP could not be shown, although an additive effect on DBP is very likely. This study supports the notion that further research is necessary to explore the role of multiple genetic markers with respect to cardiovascular risk in a general population.
